Yen Ching-Yu, Lee Sheng-Yang, Hsieh Jih-Fang, Wang Dun-Zheng, Lin Gin-Nan, Tsai Chih-Mong, Liu Shyun-Yui
Department of Oral and Maxillofacial Surgery, Chi Mei Medical Center, 901 Chung Hwa Road, Yung Kang City, Tainan 710, Taiwan.
Ann Surg Oncol. 2006 Aug;13(8):1130-5. doi: 10.1245/ASO.2006.09.023. Epub 2006 Jun 21.
Sentinel lymph node (SLN) biopsy seems to be a method that solves the problem of neck management with oral squamous cell carcinoma. Using blue dye methods for detection of neck SLNs from the surface of the operative field seems difficult; therefore, we used radiolocalization alone to detect and extract sentinel nodes. Aside from the various histological and clinical parameters examined in this procedure, we also determined whether they had any clinical significance in relation to the detection of SLNs during the operation.
Enrolled subjects had preoperative clinical N0 stage squamous cell carcinoma of the oral cavity and had received an unfiltered (99m)Tc sulfur colloid peritumoral injection. Localization of the SLNs was performed by using lymphoscintigraphy and a handheld gamma probe.
In total, 28 oral squamous cell carcinoma patients were included in this prospective study. Sixty-four SLNs in 27 patients were identified by this method. The identification rate was 96.4%. No false-negative predictions of SLN were noted among any of the patients studied. The numbers of the SLNs found during the operation were larger in patients with positive findings than those with negative findings (P < .05 by the Mann-Whitney U-test).
SLN radiolocalization provided an acceptable identification rate. The cases of positive findings for metastasis seemed to statistically have more SLNs than did those with negative findings, but more evidence is needed to prove this point. Therefore, SLN biopsies for extracting all possible high-risk nodes may be conducive for oral squamous cell carcinoma surgery.
前哨淋巴结(SLN)活检似乎是一种解决口腔鳞状细胞癌颈部处理问题的方法。从手术区域表面使用蓝色染料法检测颈部前哨淋巴结似乎很困难;因此,我们仅使用放射性定位来检测和提取前哨淋巴结。除了在此过程中检查的各种组织学和临床参数外,我们还确定了它们在手术期间对前哨淋巴结检测是否具有任何临床意义。
纳入的受试者术前临床分期为口腔N0期鳞状细胞癌,并接受了未过滤的(99m)锝硫胶体瘤周注射。通过淋巴闪烁显像和手持式γ探测器进行前哨淋巴结的定位。
本前瞻性研究共纳入28例口腔鳞状细胞癌患者。通过该方法在27例患者中识别出64个前哨淋巴结。识别率为96.4%。在任何研究的患者中均未发现前哨淋巴结的假阴性预测。手术中发现的前哨淋巴结数量在有阳性发现的患者中比在有阴性发现的患者中更多(曼-惠特尼U检验,P <.05)。
前哨淋巴结放射性定位提供了可接受的识别率。转移阳性发现的病例在统计学上似乎比阴性发现的病例有更多的前哨淋巴结,但需要更多证据来证明这一点。因此,切除所有可能的高危淋巴结的前哨淋巴结活检可能有利于口腔鳞状细胞癌手术。